Pioneers in patient-based
AI-enabled drug discovery
From Patient to drug: Human Patient derived drug candidates for next generation medicines.
Ksilink delivers innovative solutions for advanced biomedical research
& screening needs in complex human and patient derived cellular systems.
At Ksilink, we design and apply patient-based cellular disease models
and other complex cellular systems applicable for large-scale phenotypic screening to support partners, customers and our in house programs.
Our proprietary drug discovery engine applies unique AI-boosted cellular
profiling technologies to identify druggable targets and develop the most efficient compounds for novel treatment options.
